MSFT · News · 20261112N
AI Clinical Trial Optimization Growth
MICROSOFT CORP · 2026-11-12 · Importance 20 · Surprise 22
A ResearchAndMarkets report projected the global AI clinical-trial-optimization market to grow from $1.35 billion in 2025 to $1.57 billion in 2026, a 16.1% CAGR. It cited adoption by pharmaceutical, biotechnology, and clinical research organizations for trial design, patient recruitment, and data analysis. Microsoft was listed among the companies active in the market, alongside IQVIA, NVIDIA, and Oracle.